InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Tilton John, Executive. Director active across 1 company, notably Biohaven Pharmaceutical Holding Co Ltd.. In total, 4 reports have been published. History available since 25 November 2021. The latest transaction was filed on 6 January 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations4 total
1,250 shares0Common SharesSEC:0001562180-22-000357
1,250 shares0Common SharesSEC:0001562180-22-000357:0
1,250 shares0Common SharesSEC:0001562180-21-007304:0
1,250 shares0Common SharesSEC:0001562180-21-007304
4 of 4 declarations
About Tilton John
John Tilton is the Chief Commercial Officer at Biohaven Pharmaceutical Holding Co Ltd. He oversees the company's business strategies, which focus on developing innovative treatments. Biohaven is recognized for its commitment to innovation in the pharmaceutical sector. John's experience is crucial for the company's growth.
